Michael Moore becomes chairman of Oxford BioTherapeutics

Published: 21-Dec-2009
Recruitment


Oxford BioTherapeutics (OBT) has appointed Dr Michael Moore as non-executive chairman. He joins the board of OBT following five years at UK biotechnology company, Piramed, where he was chief executive until its acquisition by Roche in 2008.

Prior to joining Piramed, Dr Moore was chief scientific officer and research director of Xenova Group. During a distinguished career he has also held senior academic positions at the Paterson Institute for Cancer Research, Christie Hospital, Manchester, UK and the Brunel Institute of Cancer Genetics and Pharmacogenomics where he is still Professor Associate.

Jim Cornett, chief operating officer, Mike Gresser, chief scientific officer and Jon Terrett, vp oncology, have also recently joined the company to lead its US r&d operations.

See more

You may also like

Recruitment

Rentschler Biopharma continues hiring at global sites

Read more
During 2021, the company has hired more than 300 employees across all business functions with a strong focus on production and laboratory personnel

Trending Articles

  1. hard to swallow...
  2. People on the Move US biotechnology company <i>La Jolla Pharmaceutical</i> has promoted <b>Gail Sloan</b> to vice president of finance, controller and secretary. Sloan has previously worked with Affymax Research Institute and Ernst & Young.
  3. Bioprogress appoint new position and restructure board <p>BioProgress, the speciality pharmaceutical and healthcare company, has announced the creation of a new executive operational board, and the appointment of Keith Hemming, as head of operations in a new position within the management team of the company.</p>
  4. Drug formulation and delivery expert Dr Joseph Reo appointed as Catalent’s Director of Global Scientific Affairs Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, has announced the appointment of Dr Joseph (Joe) Reo to the role of Director of Global Scientific Affairs
  5. People on the move

Upcoming event

Enhancing probiotic stability through smarter formulation and packaging strategies

18 September 2025 | Virtual See all

You may also like

Recruitment

Rentschler Biopharma continues hiring at global sites

During 2021, the company has hired more than 300 employees across all business functions with a strong focus on production and laboratory personnel
Recruitment

Vetter Pharma invests $4.1m in Ravensburg training facility

The centre opened on September 14, with a small celebration held for management, training management and trainees.
Recruitment

Does pharma have a problem with inclusivity and innovation?

As we’ve seen only too clearly in recent weeks, the pharmaceutical industry is of paramount importance to the global economy and society. The collaboration regarding the COVID-19 pandemic is an example of the sector at its best, reports Stephen Frost, Founder, Frost Included
Recruitment

Cell Mogrify undergoes period of change

A cash injection and change in leadership gives momentum to the cell therapy company for direct cellular conversion platform
Recruitment

Novartis scoops Top Employer award

Novartis UK and its subsidiary, Sandoz, have been certified as ‘Top Employers’ of 2019 by Top Employers Institute
Recruitment

Retention, not just recruitment

Six ways to protect your company from the skills crisis
Recruitment

Particle Testing Authority (PTA) boosts company's thermal analysis capabilities

Particle Testing Authority (PTA), a division of Micromeritics Instrument Corporation, now has expanded thermal analysis capabilities with addition of Bryan Shaw to its team
Subscribe now